4th Quarter - Report

KNIGHT CAPITOL CONSULTANTS for EQUASHIELD, LLC

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Labor Issues/Antitrust/Workplace LBR

Efforts to ensure worker safety in the administration of hazardous chemicals (no specific legislation).

Foreign entity interest: Equashield Medical, LTD is the parent company of Equashield, LLC

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch; Health Policy Director, Senator Orrin G. Hatch

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC)

Pharmacy PHA

Provisions affecting vial reuse being discussed in conjunction with any pending legislation, including the Prescription Drug Pricing Reduction Act of 2019 (S. 2543)

Foreign entity interest: Equashield Medical, LTD is the parent company of Equashield, LLC

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 2543 (116th)

Budget/Appropriations BUD

Efforts by the National Institute on Occupational Safety and Health to develop testing methods for hazardous chemical use in hospitals (The Consolidated Appropriations Act of 2021, PL 116-260).

Foreign entity interest: Equashield Medical, LTD is the parent company of Equashield, LLC

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch

Contacted: Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.